Biotransformation of protriptyline by filamentous fungi and yeasts

Xenobiotica

Volumn 29, Issue 7, 1999, Pages 733-746

  Duhart, Jr ^a   Zhang, D ^a   Deck, J ^a   Freeman, J P ^a   Cerniglia, C E ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; PROTRIPTYLINE;

ARTICLE; BIOTRANSFORMATION; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; CUNNINGHAMELLA; DRUG METABOLISM; FUNGUS; FUSARIUM MONILIFORME; FUSARIUM OXYSPORUM; FUSARIUM SOLANI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; YEAST;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BIOTRANSFORMATION; CAENORHABDITIS ELEGANS; CANDIDA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FUNGI; FUSARIUM; MAGNETIC RESONANCE SPECTROSCOPY; PROTRIPTYLINE; YEASTS;

CAENORHABDITIS ELEGANS; CUNNINGHAMELLA ECHINULATA; CUNNINGHAMELLA ELEGANS; CUNNINGHAMELLA PHAEOSPORA; FUNGI; FUSARIUM OXYSPORUM; FUSARIUM SOLANI; FUSARIUM SP.; GIBBERELLA FUJIKUROI; MAMMALIA; PHAEOSPORA;

EID: 0032778340     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982599238353     Document Type: Article

References (22)

1. AYD, F. J., 1968, A clinical appraisal of protriptyline (vivactil): the latest FDA approved antidepressant. Lippincott's Medical Science, 54-59.
2. BELVEDERE, G., FRIGERIO, A., PANTAROTTO, C., ROVEL, V., ZANOL, M., PARRAVICINI, F. and PIFFERI, G., 1975, Mass spectrometric identification of 10,11-dihydro-10,11-dihydroxyprotriptyline in rat urine after administration of protriptyline. Farmaco Edizione Scientifica, 30, 904-911.
3. CLARK, A. M. and HUFFORD, C. D., 1991, Use of microorganisms for the studies of drug metabolism: an update. Medicinal Research Reviews, 2, 473-501.
4. COUDONE, F., FIALIP, J., ESCHALIER, A. and LAVARENNE, J., 1994. Plasma and brain pharmacokinetics of amitriptyline and its demethylated and hydroxylated metabolites after acute intraperitoneal injection in mice. European Journal of Drug Metabolism and Pharmacokinetics, 19, 5-11.
5. DAVIS, P. J., 1988, Microbial models of mammalian drug metabolism. Developments in Industrial Microbiology, 29, 197-219.
6. HANSEN, E, B., JR, CERNIGLIA, C. E., KORFMACHER, W. A., MILLER, D. W. and HEFLICH, R. H., 1987, Microbial transformation of the antihistamine pyrilamine maleate: formation of potential mammalian metabolites. Drug Metabolism and Disposition, 15, 97-106.
7. HEZARI, M. and DAVIS, P. J., 1992, Microbial models of mammalian metabolism: N-dealkylation of furosemide to yield the mammalian metabolite CSA using Cunninghamella elegans. Drug Metabolism and Disposition, 20, 882-888.
8. HEZARI, M. and DAVIS, P. J., 1993, Microbial models of mammalian metabolism: furosemide glucoside formation using the fungus Cunninghamella elegans. Drug Metabolism and Disposition, 21, 259-267.
9. HUCKER, H. B., BALLETTO, A. J., DEMETRIADES, J., ARISON, B. H. and ZACCHEI, A. G., 1974, Epoxide metabolites of protriptyline in rat urine. Drug Metabolism and Disposition, 3, 80-84.
10. HUCKER, H. B., BALLETTO, A. J., ZACCHEI, A. G. and ARISON, B, H., 1979, Metabolism of protriptyline by rabbit liver in vitro. Pharmacology, 19, 278-281.
11. HUFFORD, C. D., CAPITON, G. A., CLARK, A. M. and BAKER, J. K., 1981, Metabolism of imipramine by microorganisms. Journal of Pharmaceutical Sciences, 70, 151-155.
12. MELLSTROM, B. and VON BAHR, C., 1981, Demethylation and hydroxylation of amitriptyline, nortriptyline, and 10-hydroxyamitriptyline in human liver microsomes. Drug Metabolism and Disposition, 9, 565-568.
13. MERCK, SHARPE & DOHME, 1968, Protriptyline HC1. Clinical Pharmacology and Therapeutics, 9, 409-412.
14. ROSAZZA, J. P. and SMITH, R. V., 1979, Microbial models for drug metabolism. Advances in Applied Microbiology, 25, 169-207.
15. ROVEI, V., BELVEDERE, G., PANTAROTTO, C. and FRIGERIO, A., 1976, Isolation of 10,11-epoxide of protriptyline in rat urine after protriptyline administration. Journal of Pharmaceutical Sciences, 65, 810-815.
16. SHOUN, H., SUDO, Y. and BEPPU, T., 1985, Subterminal hydroxylation of fatty acids by a cytochrome P-450 dependent enzyme system from a fungus, Fusarium oxysporum. Journal of Biochemistry, 97, 755-763.
17. SHOUN, H., SUDO, Y., SETO, Y. and BEPPU, T., 1983, Purification and properties of a cytochrome P-450 of a fungus, Fusarium oxysporum. Journal of Biochemistry, 94, 1219-1229.
18. SISENWINE, S., TIO, C. O., SHRADER, S. R. and RUELIUS, H. W., 1976, The biotransformation of protriptyline in man, pig, and dog. Journal of Pharmacology and Experimental Therapeutics, 175, 51-59.
19. YANG, W. and DAVIS, P. J., 1992, Microbial models of mammalian metabolism: biotransformations of N-methylcarbazole using the fungus Cunninghamella echinulata. Drug Metabolism and Disposition, 20, 38-46.
20. ZHANG, D., EVANS, F. E., FREEMAN, J. P., DUHART, B. T., JR and CERNICLIA, C. E., 1995a, Biotransformation of amitriptyline by Cunninghamella elegans. Drug Metabolism and Disposition, 23, 1417-1425.
21. ZHANG, D., EVANS, F. E., FREEMAN, J. P., YANG, Y., DECK, J. and CERNIGLIA, C. E., 1995b, Formation of mammalian metabolites of cyclobenzaprine by the fungus, Cunninghamella elegans. ChemicoBiological Interactions, 102, 79-92.
22. ZHANG, D., YANG, Y., LEAKEY, J. E. A. and CERNIGLIA, C. E., 1996, Phase I and Phase II enzymes produced by Cunninghamella elegans for the metabolism of xenobiotics. FEMS Microbiology Letters, 138, 221-226.